Product Licensing

Technology firm, Albert Einstein College of Medicine sign license agreement

Published in Blood Weekly, December 1st, 2005

Spherix Incorporated (SPEX), a Maryland technology firm, announced that it has signed a license agreement with the Albert Einstein College of Medicine, Bronx, New York, covering certain medicinal uses of Naturlose.

Under its license, the BioSpherix Division of Spherix gains the rights to Naturlose-containing products and processes under development at Einstein that enhance storage lifetimes of medicinal proteins, including blood components; Spherix will pay royalties to Einstein on sales of any forthcoming patented products or processes. Spherix will continue funding the Naturlose research at Einstein.

Cooperation between Spherix and Einstein, a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2005-12-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry